Amarin Corp. (AMRN) - Hot FDA News

Amarin Corp. (AMRN) – Hot FDA News

Jun 30, 2022 04:06 PM Amarin Corp. (AMRN) Announces REDUCE-IT Exploratory Post Hoc Biomarker Sub-Analysis Shows Relatively Small Changes in Inflammatory Markers Between Icosapent Ethyl and Placebo
Oct 15, 2020 04:31 PM Amarin Corp. (AMRN) Says VASCEPA Found to Significantly Reduce Ischemic Events in Patients with Prior PCI in Post Hoc Subgroup Analyses of Landmark REDUCE-IT Study Presented at Transcatheter Cardiovas
May 14, 2020 02:51 PM
Mar 30, 2020 04:52 PM
Dec 13, 2019 04:29 PM
Nov 14, 2019 05:35 PM
Nov 14, 2019 04:08 PM
Nov 12, 2019 08:22 AM
Nov 12, 2019 08:18 AM
Aug 8, 2019 04:31 PM
Sep 24, 2018 06:17 AM
Sep 25, 2017 06:06 AM
Jun 12, 2017 07:05 AM
Sep 12, 2016 07:15 AM
Aug 7, 2015 10:48 AM
May 7, 2015 04:18 PM
Sep 12, 2014 09:02 AM
Feb 21, 2014 04:02 PM
Feb 21, 2014 02:29 PM
Jan 21, 2014 07:04 AM
Dec 20, 2013 06:11 AM
Jul 26, 2012 04:28 PM
Apr 18, 2011 07:43 AM
Nov 29, 2010 06:39 AM